Mandating flu shot availability for healthcare workers saves patient lives

Hospitals required by state laws to offer healthcare workers flu shots can expect significantly reduced flu and pneumonia mortality compared with hospitals in states forgoing such mandates.

The conclusion comes from a study published January 5 in Annals of Internal Medicine.

Corresponding author Emily Lawler, PhD, of the University of Georgia and colleagues hypothesized an association between the relevant laws and reduced flu cases and death.

Using multiple systematic means of investigating the association, they found state vaccination laws corresponded with a 2.5% reduction in poor flu-related outcomes.

The effect was most pronounced among the elderly and most evident in years when the vaccine was on target for circulating strains.

Lawler and co-authors comment that, during the 2016-17 influenza year, when 15 states had laws in place, more than 1,800 lives were preserved.

“State laws promoting hospital worker vaccination against influenza may be effective in preventing pneumonia- and influenza-related deaths, particularly among elderly persons,” they conclude. “Vaccinating hospital workers may substantially reduce the spread of influenza and protect the most vulnerable populations.”

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

After their proposal for a new American Board of Cardiovascular Medicine was shot down earlier this year, cardiology groups have asked the AMA for some support. "We feel like it's time for us to blaze our own path," one specialist explained. 

The company has agreed to acquire Verve Therapeutics for an upfront payment of approximately $1 billion. The total could increase significantly, however, if certain milestones are met. One of Verve's biggest gene therapies has already received the FDA's fast track designation.

American College of Cardiology Board of Governors Chair David E. Winchester, MD, MS, examines the many benefits of working with the American Medical Association House of Delegates to bring about significant change.